|
1
|
Ross R: The pathogenesis of
atherosclerosis: a perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Augé N, Maupas-Schwalm F, Elbaz M, Thiers
JC, Waysbort A, Itohara S, Krell HW, Salvayre R and Nègre-Salvayre
A: Role for matrix metalloproteinase-2 in oxidized low-density
lipoprotein-induced activation of the sphingomyelin/ceramide
pathway and smooth muscle cell proliferation. Circulation.
110:571–578. 2004.
|
|
3
|
Aoyagi M, Yamamoto M, Azuma H, Nagashima
G, Niimi Y, Tamaki M, Hirakawa K and Yamamoto K: Immunolocalization
of matrix metalloproteinases in rabbit carotid arteries after
balloon denudation. Histochem Cell Biol. 109:97–102. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Newby AC and Zaltsman AB: Fibrous cap
formation or destruction - the critical importance of vascular
smooth muscle cell proliferation, migration and matrix formation.
Cardiovasc Res. 41:345–360. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caird J, Napoli C, Taggart C, Farrell M
and Bouchier-Hayes D: Matrix metalloproteinases 2 and 9 in human
atherosclerotic and non-atherosclerotic cerebral aneurysms. Eur J
Neurol. 13:1098–1105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruby AJ, Kuttan G, Babu KD, Rajasekharan
KN and Kuttan R: Anti-tumour and antioxidant activity of natural
curcuminoids. Cancer Lett. 94:79–83. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Surh YJ: Anti-tumor promoting potential of
selected spice ingredients with antioxidative and anti-inflammatory
activities: a short review. Food Chem Toxicol. 40:1091–1097. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008.
|
|
9
|
Kamimura M, Bea F, Akizawa T, Katus HA,
Kreuzer J and Viedt C: Platelet-derived growth factor induces
tissue factor expression in vascular smooth muscle cells via
activation of Egr-1. Hypertension. 44:944–951. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang W, Lim S, Song H, Song BW, Kim HJ,
Cha MJ, Sung JM, Kim TW and Hwang KC: Cordycepin inhibits vascular
smooth muscle cell proliferation. Eur J Pharmacol. 597:64–69. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu YM and Lin HC: Curcumin prevents human
aortic smooth muscle cells migration by inhibiting of MMP-9
expression. Nutr Metab Cardiovasc Dis. 20:125–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schwartz SM, Heimark RL and Majesky MW:
Developmental mechanisms underlying pathology of arteries. Physiol
Rev. 70:1177–1209. 1990.PubMed/NCBI
|
|
13
|
Owens GK: Regulation of differentiation of
vascular smooth muscle cells. Physiol Rev. 75:487–517.
1995.PubMed/NCBI
|
|
14
|
Lijnen HR: Plasmin and matrix
metalloproteinases in vascular remodeling. Thromb Haemost.
86:324–333. 2001.PubMed/NCBI
|
|
15
|
Sheu MJ, Lin HY, Yang YH, Chou CJ, Chien
YC, Wu TS and Wu CH: Demethoxycurcumin, a major active curcuminoid
from Curcuma longa, suppresses balloon injury induced
vascular smooth muscle cell migration and neointima formation: An
in vitro and in vivo study. Mol Nutr Food Res. 57:1586–1597.
2013.PubMed/NCBI
|
|
16
|
Baeuerle PA and Baltimore D: I kappa B: a
specific inhibitor of the NF-kappa B transcription factor. Science.
242:540–546. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baud V and Karin M: Signal transduction by
tumor necrosis factor and its relatives. Trends Cell Biol.
11:372–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: a pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee B and Moon SK: Resveratrol inhibits
TNF-alpha-induced proliferation and matrix metalloproteinase
expression in human vascular smooth muscle cells. J Nutr.
135:2767–2773. 2005.
|
|
20
|
McKellar GE, McCarey DW, Sattar N and
McInnes IB: Role for TNF in atherosclerosis? Lessons from
autoimmune disease. Nat Rev Cardiol. 6:410–417. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Newby AC: Metalloproteinase expression in
monocytes and macrophages and its relationship to atherosclerotic
plaque instability. Arterioscler Thromb Vasc Biol. 28:2108–2114.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK,
Park JY, Lee KU, Kim JG and Lee IK: Alpha-lipoic acid inhibits
matrix metalloproteinase-9 expression by inhibiting NF-kappaB
transcriptional activity. Exp Mol Med. 39:106–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim CH and Moon SK:
Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase
arrest of cell cycle and inhibits matrix metalloproteinase-9
expression in TNF-alpha-induced vascular smooth muscle cells. Arch
Biochem Biophys. 435:264–272. 2005. View Article : Google Scholar
|
|
25
|
Gloire G, Legrand-Poels S and Piette J:
NF-kappaB activation by reactive oxygen species: fifteen years
later. Biochem Pharmacol. 72:1493–1505. 2006.PubMed/NCBI
|
|
26
|
Schreck R, Rieber P and Baeuerle PA:
Reactive oxygen intermediates as apparently widely used messengers
in the activation of the NF-kappa B transcription factor and HIV-1.
EMBO J. 10:2247–2258. 1991.PubMed/NCBI
|
|
27
|
Janssen-Heininger YM, Poynter ME and
Baeuerle PA: Recent advances towards understanding redox mechanisms
in the activation of nuclear factor kappaB. Free Radic Biol Med.
28:1317–1327. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bar-Shai M, Carmeli E, Ljubuncic P and
Reznick AZ: Exercise and immobilization in aging animals: the
involvement of oxidative stress and NF-kappaB activation. Free
Radic Biol Med. 44:202–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
